 |
MEND-1 Trial
In 2003, Medicure announced results from its Phase II clinical trial called MEND-1. The clinical study was managed by the Duke Clinical Research Institute (DCRI) in Durham, North Carolina, a recognized leader in cardiovascular clinical trials, clinical drug research and the evaluation of novel therapeutics. MEND-1 was conducted at four cardiac centers in Canada and the United States under the direction of Principal Investigator, Dr. James E. Tcheng. MD, F.A.C.C., Associate Professor of Medicine, Duke University Medical Centre. Dr. Tcheng is an internationally regarded leader in interventional cardiology and clinical trials. Dr. Robert A. Harrington, MD, F.A.C.C., is the director of cardiovascular clinical trials at DCRI and oversaw the management of the clinical trial.
|
|
